{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-099695","form_type":"8-K","ticker":null,"cik":"0001567892","company_name":"Keenova Therapeutics plc","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.366757+00:00","generated_at":"2026-06-10T21:41:19.962029+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Mallinckrodt enters $250M DIP loan, draws $150M; shares delisted to OTC under MNKTQ","bullets":["Entered $250M superpriority DIP term loan; initial draw of $150M on Sept 8, 2023; $100M available upon final court order.","Interest at SOFR + 8% (1% floor); 12% backstop commitment fee paid in kind by increasing DIP loan principal.","Proceeds fund working capital and corporate purposes per approved budget during Chapter 11 proceedings.","Ordinary shares delisted from NYSE American on Sept 6, 2023; now trade OTC under symbol MNKTQ.","DIP matures 12 months post-petition or upon plan effective date, unless converted to new takeback term loans."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-099695","json":"https://secwatch.observer/filing/0001104659-23-099695.json","markdown":"https://secwatch.observer/filing/0001104659-23-099695.md","text":"https://secwatch.observer/filing/0001104659-23-099695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923099695/0001104659-23-099695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923099695/tm2325834d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:41:19.962029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ea6345840af01b8843d1f0f2b15493eb51ce2181","claim":"Keenova Therapeutics plc incurred credit facility of $250 million with Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents at SOFR plus 8.00% maturing the earliest of: (a) the date that is 12 months after the Petition Date....","evidence_excerpt":"On September 8, 2023, the Company, the DIP Borrowers and the other parties thereto entered into the DIP Credit Agreement, which provides the following: · The DIP Lenders will provide a priming, senior secured, super-priority debtor-in-possession term loan facility in the aggregate principal amount (exclusive of capitalized fees) of $250 million","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923099695/0001104659-23-099695-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$250 million"},{"label":"Counterparty","value":"Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents"},{"label":"Rate","value":"SOFR plus 8.00%"},{"label":"Maturity","value":"the earliest of: (a) the date that is 12 months after the Petition Date..."},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"032c597028111de8d77ab0c2483c0212a3a1a6f6","claim":"Keenova Therapeutics plc entered into Senior Secured Debtor-In-Possession Credit Agreement with Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents, and Acquiom Agency Services LLC, as collateral agent valued at $250 million (effective 2023-09-08).","evidence_excerpt":"On September 8, 2023, the Company, the DIP Borrowers and the other parties thereto entered into the DIP Credit Agreement, which provides the following: · The DIP Lenders will provide a priming, senior secured, super-priority debtor-in-possession term loan facility in the aggregate principal amount (exclusive of capitalized fees) of $250 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465923099695/0001104659-23-099695-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Acquiom Agency Services LLC and Seaport Loan Products LLC, as co-administrative agents, and Acquiom Agency Services LLC, as collateral agent"},{"label":"Value","value":"$250 million"},{"label":"Effective","value":"2023-09-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}